Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival - PubMed (original) (raw)
. 2004 Jul 1;101(1):3-27.
doi: 10.1002/cncr.20288.
Affiliations
- PMID: 15221985
- DOI: 10.1002/cncr.20288
Free article
Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival
Ahmedin Jemal et al. Cancer. 2004.
Free article
Abstract
Background: The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate annually to provide updated information regarding cancer occurrence and trends in the U.S. This year's report features a special section on cancer survival.
Methods: Information concerning cancer cases was obtained from the NCI, CDC, and NAACCR and information concerning recorded cancer deaths was obtained from the CDC. The authors evaluated trends in age-adjusted cancer incidence and death rates by regression models and described and compared survival rates over time and across racial/ethnic populations.
Results: Incidence rates for all cancers combined decreased from 1991 through 2001, but stabilized from 1995 through 2001 when adjusted for delay in reporting. The incidence rates for female lung cancer decreased (although not statistically significant for delay adjusted) and mortality leveled off for the first time after increasing for many decades. Colorectal cancer incidence rates also decreased. Death rates decreased for all cancers combined (1.1% per year since 1993) and for many of the top 15 cancers occurring in men and women. The 5-year relative survival rates improved for all cancers combined and for most, but not all, cancers over 2 diagnostic periods (1975-1979 and 1995-2000). However, cancer-specific survival rates were lower and the risk of dying from cancer, once diagnosed, was higher in most minority populations compared with the white population. The relative risk of death from all cancers combined in each racial and ethnic population compared with non-Hispanic white men and women ranged from 1.16 in Hispanic white men to 1.69 in American Indian/Alaska Native men, with the exception of Asian/Pacific Islander women, whose risk of 1.01 was similar to that of non-Hispanic white women.
Conclusions: The continued measurable declines for overall cancer death rates and for many of the top 15 cancers, along with improved survival rates, reflect progress in the prevention, early detection, and treatment of cancer. However, racial and ethnic disparities in survival and the risk of death from cancer, and geographic variation in stage distributions suggest that not all segments of the U.S. population have benefited equally from such advances.
Published 2004 by the American Cancer Society.
Similar articles
- Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW. Edwards BK, et al. J Natl Cancer Inst. 2005 Oct 5;97(19):1407-27. doi: 10.1093/jnci/dji289. J Natl Cancer Inst. 2005. PMID: 16204691 - Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations.
Howe HL, Wu X, Ries LA, Cokkinides V, Ahmed F, Jemal A, Miller B, Williams M, Ward E, Wingo PA, Ramirez A, Edwards BK. Howe HL, et al. Cancer. 2006 Oct 15;107(8):1711-42. doi: 10.1002/cncr.22193. Cancer. 2006. PMID: 16958083 - Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival.
Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson B, Mariotto A, Lake AJ, Wilson R, Sherman RL, Anderson RN, Henley SJ, Kohler BA, Penberthy L, Feuer EJ, Weir HK. Jemal A, et al. J Natl Cancer Inst. 2017 Sep 1;109(9):djx030. doi: 10.1093/jnci/djx030. J Natl Cancer Inst. 2017. PMID: 28376154 Free PMC article. - Epidemiology of cancer among Hispanics in the United States.
Trapido EJ, Burciaga Valdez R, Obeso JL, Strickman-Stein N, Rotger A, Pérez-Stable EJ. Trapido EJ, et al. J Natl Cancer Inst Monogr. 1995;(18):17-28. J Natl Cancer Inst Monogr. 1995. PMID: 8562218 Review. - Interpreting cancer trends.
Ward EM, Thun MJ, Hannan LM, Jemal A. Ward EM, et al. Ann N Y Acad Sci. 2006 Sep;1076:29-53. doi: 10.1196/annals.1371.048. Ann N Y Acad Sci. 2006. PMID: 17119192 Review.
Cited by
- Reactive oxygen species and aldehyde dehydrogenase 1A as prognosis and theragnostic biomarker in acute myeloid leukaemia patients.
Venton G, Colle J, Tichadou A, Quessada J, Baier C, Labiad Y, Perez M, De Lassus L, Loosveld M, Arnoux I, Abbou N, Ceylan I, Martin G, Costello R. Venton G, et al. J Cell Mol Med. 2024 Oct;28(19):e70011. doi: 10.1111/jcmm.70011. J Cell Mol Med. 2024. PMID: 39392121 Free PMC article. - A Cross-Sectional Survey of Healthcare Professionals' Knowledge, Attitude and Current Behaviours towards Female Fertility Preservation Services within the UK.
Kasaven LS, Mitra A, Chawla M, Murugesu S, Anson N, Ben Nagi J, Theodorou E, Rimmer MP; UKARCOG Working Group; Al-Wattar B, Yazbek J, Jones BP, Saso S. Kasaven LS, et al. Cancers (Basel). 2024 Jul 25;16(15):2649. doi: 10.3390/cancers16152649. Cancers (Basel). 2024. PMID: 39123377 Free PMC article. - Participatory action research to develop and implement multicomponent, multilevel strategies for implementing colorectal cancer screening interventions in American Indian communities in New Mexico.
Adsul P, English K, Jim C, Pankratz VS, Edwardson N, Sheche J, Rodman J, Charlie J, Pagett J, Trujillo J, Grisel-Cambridge J, Mora S, Yepa KL, Mishra SI. Adsul P, et al. Implement Sci Commun. 2024 May 10;5(1):55. doi: 10.1186/s43058-024-00591-y. Implement Sci Commun. 2024. PMID: 38730301 Free PMC article. - Impact of NOX4 Knockout by CRISPR/Cas9 on the MCF-7, HCA-7 and UM-RC-6 Cancer Cells.
Javadi M, Sazegar H, Doosti A. Javadi M, et al. Iran J Biotechnol. 2022 Oct 1;20(4):e3115. doi: 10.30498/ijb.2022.298496.3115. eCollection 2022 Oct. Iran J Biotechnol. 2022. PMID: 38344320 Free PMC article. - Why Does Your Uterus Become Malignant? The Impact of the Microbiome on Endometrial Carcinogenesis.
Morańska K, Englert-Golon M, Durda-Masny M, Sajdak S, Grabowska M, Szwed A. Morańska K, et al. Life (Basel). 2023 Nov 28;13(12):2269. doi: 10.3390/life13122269. Life (Basel). 2023. PMID: 38137870 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources